HOUSTON, Aug. 28, 2025 /PRNewswire/ -- Stramsen Biotech Inc. has successfully submitted a Pre-Investigational New Drug (Pre-IND) meeting request, accompanied by a comprehensive Pre-IND package, to the ...
BioCorRx has submitted its pre-Investigational New Drug package to the FDA) for the company's naltrexone implant, BICX102. The pre-IND package provides the FDA with current information on BICX102, as ...
Mydecine Innovations (OTCPK:MYCOF) submitted a pre-investigational new drug (IND) briefing package to the U.S. Food and Drug Administration (FDA) for a clinical study evaluating MYCO-001 in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback